Alessandro Squizzato Selected Research

Factor VIIa (Activated Factor VII)

8/2015	Management of disseminated intravascular coagulation: a survey of the International Society on Thrombosis and Haemostasis.
5/2007	Recombinant activated factor VII as a general haemostatic agent: evidence-based efficacy and safety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Squizzato Research Topics

Disease

24	Hemorrhage 01/2022 - 12/2005
18	Pulmonary Embolism 01/2022 - 11/2005
16	Thrombosis (Thrombus) 09/2021 - 12/2005
14	Venous Thromboembolism 01/2021 - 05/2004
12	Venous Thrombosis (Deep-Vein Thrombosis) 09/2021 - 01/2003
12	Neoplasms (Cancer) 03/2021 - 05/2004
11	Ischemic Stroke 01/2022 - 11/2005
11	Atrial Fibrillation 01/2021 - 12/2009
10	Stroke (Strokes) 01/2022 - 07/2013
4	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2010
4	Infections 01/2020 - 08/2011
4	Disseminated Intravascular Coagulation 01/2020 - 05/2012
4	Acute Coronary Syndrome 09/2018 - 12/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 12/2009
3	Transient Ischemic Attack 01/2022 - 08/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 09/2021 - 09/2008
3	Peripheral Arterial Disease 01/2018 - 01/2011
3	Liver Diseases (Liver Disease) 12/2014 - 05/2007
3	Hypothyroidism 05/2014 - 04/2012
2	Breast Neoplasms (Breast Cancer) 12/2021 - 03/2021
2	Disease Susceptibility (Diathesis) 09/2021 - 05/2007
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2021 - 08/2019
2	Sepsis (Septicemia) 01/2020 - 05/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2018
2	Vascular Diseases (Vascular Disease) 01/2020 - 12/2019
2	Inflammation (Inflammations) 12/2019 - 08/2011
2	Rhabdomyolysis 01/2019 - 08/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 04/2015
2	Myocardial Infarction 01/2018 - 12/2017
2	Chronic Hepatitis C 01/2018 - 12/2014
2	Coronary Disease (Coronary Heart Disease) 12/2017 - 01/2011
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2017 - 01/2011
2	Embolism (Embolus) 10/2015 - 12/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 07/2009
2	Hyperthyroidism 12/2012 - 12/2007
2	Thromboembolism 09/2011 - 12/2005
2	Obesity 08/2009 - 10/2006
2	Thrombophilia 08/2009 - 10/2006
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Psoriatic Arthritis 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 09/2021
1	Factor XII Deficiency 09/2021
1	Fever (Fevers) 06/2021
1	Cardiotoxicity 03/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	Ascites 12/2020
1	Hepatitis C 11/2020

Drug/Important Bio-Agent (IBA)

22	AnticoagulantsIBA 01/2021 - 12/2005
10	Vitamin K FDA Link 01/2021 - 05/2004
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 07/2008
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2011
6	fibrin fragment D (D-dimer)IBA 09/2021 - 11/2005
5	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 05/2004
5	Pharmaceutical PreparationsIBA 11/2020 - 12/2009
4	Clopidogrel (Plavix)FDA Link 01/2022 - 01/2011
4	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 05/2012
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2019 - 01/2011
3	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 12/2010
3	von Willebrand FactorIBA 09/2021 - 08/2009
3	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2014 - 06/2010
3	Warfarin (Coumadin)FDA LinkGeneric 01/2013 - 01/2003
2	Hormones (Hormone)IBA 12/2021 - 02/2011
2	AntibodiesIBA 09/2021 - 12/2007
2	Antiviral Agents (Antivirals)IBA 11/2020 - 01/2018
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 09/2018
2	oxidized low density lipoproteinIBA 01/2018 - 10/2017
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 06/2017 - 01/2015
2	LipidsIBA 01/2016 - 05/2010
2	Factor VIIa (Activated Factor VII)IBA 08/2015 - 05/2007
2	Fibric Acids (Fibrates)IBA 12/2012 - 05/2010
2	Hemostatics (Antihemorrhagics)IBA 07/2012 - 08/2009
1	TicagrelorIBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2021
1	Janus Kinase InhibitorsIBA 10/2021
1	AnthracyclinesIBA 03/2021
1	edoxabanIBA 01/2021
1	Human Serum Albumin FDA LinkGeneric 12/2020
1	SaltsIBA 12/2020
1	DiureticsIBA 12/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2020
1	Cytochrome P-450 CYP3AIBA 11/2020
1	CreatinineIBA 01/2020

Therapy/Procedure

21	Therapeutics 01/2022 - 05/2004
5	Secondary Prevention 01/2022 - 07/2008
4	Stents 01/2020 - 04/2015
3	Thrombolytic Therapy 01/2022 - 04/2015
3	Drug Therapy (Chemotherapy) 03/2021 - 01/2012
3	Percutaneous Coronary Intervention 01/2020 - 10/2011
3	Length of Stay 12/2019 - 08/2017
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2016 - 08/2015
2	Catheters 01/2016 - 06/2009
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2015 - 10/2011
1	Duration of Therapy 01/2022
1	Preoperative Period 09/2021
1	Thermometers 06/2021
1	Transjugular Intrahepatic Portasystemic Shunt 12/2020
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2020
1	Liver Transplantation 12/2020